Search

Your search keyword '"Chukwuemeka Uzoka"' showing total 9 results
Start Over Author "Chukwuemeka Uzoka"
9 results on '"Chukwuemeka Uzoka"'

2. List of Contributors

Author

Zaid Abdel Rahman, Syed Ali Abutalib, Aimaz Afrough, Sairah Ahmed, Taha Al-Juhaishi, Amin M Alousi, Leonard C. Alsfeld, Farrukh T. Awan, Ahsan Azhar, Qaiser Bashir, Brandon Douglas Brown, Kai Cao, Richard E. Champlin, Hua-Jay J. Cherng, Stefan O. Ciurea, Bouthaina Dabaja, May Daher, Marcos De Lima, Christen M. Dillard, Penny Fang, Marcelo A. Fernández Viña, Christopher James Ferreri, Fateeha Furqan, Nico Gagelmann, Praveen Ramakrishnan Geethakumari, Sassine Ghanem, Uri Greenbaum, Alison M. Gulbis, Ali Haider, Mehdi Hamadani, Victoria Wehr Handy, Misha C. Hawkins, Ella J. Ariza Heredia, Chitra Hosing, Jin Seon Im, Nitin Jain, Andrew P Jallouk, Mika L. Jankowski, Brandon J. Kale, Partow Kebriaei, Lana Khalil, Irum Khan, Sajad Khazal, Piyanuch Kongtim, Paul Lin, Kris M. Mahadeo, Alexandre E Malek, Kara McGee, Rohtesh S. Mehta, Victor Eduardo Mulanovich, Pashna N. Munshi, Loretta J. Nastoupil, Sattva S Neelapu, Yago Nieto, Amanda Olson, Betul Oran, Folashade Otegbeye, Akshat Maneesh Patel, Krina Patel, Prince Paul, Naveen Pemmaraju, Uday R Popat, Muzaffar H. Qazilbash, Hind Rafei, Dristhi S Ragoonanan, Jeremy L. Ramdial, Katayoun Rezvani, Ana Avila Rodriguez, Gabriela Rondón, Supawee Saengboon, Gabriela Sanchez-Petitto, Terri Lynn Shigle, Elizabeth J. Shpall, Samer A. Srour, Raphael E. Steiner, Karen R. Stolar, Paolo Strati, Nicholas A. Szewczyk, Mark R. Tanner, Kevin Tang, Peter F. Thall, Sudhakar Tummala, Chukwuemeka Uzoka, Whitney D. Wallis, Jason R. Westin, Nathaniel R. Wilson, Susan Wu, Eduardo Yepez Guevara, and Jun Zou

Published
2024
Full Text
View/download PDF

3. High Dose Total Marrow Irradiation (TMI) Does Not Increase the Risk of Long-Term Toxicity to Myeloablative Fludarabine/Busulfan Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Author

Lucas Maahs, Karen Sweiss, Chukwuemeka Uzoka, Nadim Mahmud, Zhengjia Chen, Ziqiao Xu, Ana Maria Avila, Carlos Galvez, Matthew Koshy, and Damiano Rondelli

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2023
Full Text
View/download PDF

4. A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)

Author

Ana Maria Avila, Saad Arain, Karen Sweiss, Pritesh Patel, Samin Houshyar, Gregory S Calip, Irum Khan, Paul G. Rubinstein, Chukwuemeka Uzoka, and John G. Quigley

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022
Full Text
View/download PDF

8. Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience

Author

Yuankai Lin, Damiano Rondelli, Nadim Mahmud, Elena Tepak, Xinhe Wang, Youngmin Park, Sally Campbell-Lee, David Peace, Chukwuemeka Uzoka, Li C Liu, Santosh L. Saraf, Karen Sweiss, and Pritesh R. Patel

Subjects
Oncology, Adult, Male, medicine.medical_specialty, CD34, Antigens, CD34, 030204 cardiovascular system & hematology, Single Center, Transplantation, Autologous, Body Mass Index, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Granulocyte Colony-Stimulating Factor, medicine, Ethnicity, Humans, Transplantation, Homologous, Progenitor cell, Multiple myeloma, Aged, Retrospective Studies, Mobilization, business.industry, Plerixafor, Stem Cells, Hematopoietic Stem Cell Transplantation, Hematology, General Medicine, Middle Aged, medicine.disease, Hematopoietic Stem Cells, Hematopoietic Stem Cell Mobilization, United States, Black or African American, Haematopoiesis, Multivariate Analysis, Blood Component Removal, Female, business, Multiple Myeloma, Body mass index, 030215 immunology, medicine.drug
Abstract

Background Whether race/ethnicity plays a role in hematopoietic stem/progenitor cells (HSPC) mobilization in autologous donors has not been studied. We hypothesize that donor characteristic including race/ethnicity, age, sex, body mass index, and diagnostic groups influences HSPC mobilization. Diagnostic groups include healthy allogeneic donors, autologous multiple myeloma (MM) and non-MM donors. Study design and methods Here, we conducted a single-center retrospective study in 64 autologous patients and 48 allogeneic donors. Autologous donors were patients diagnosed with MM or non-MM. All donors were grouped as African American (AA), White (W), or "Other"(O). Results Multivariate analysis demonstrated diagnostic group differences for CD34+ cell yields between race/ethnicity. Specifically, non-MM patients had the lowest CD34+ cell yields in AA and O, but not in W. For pre-apheresis peripheral blood (PB) CD34+ cell numbers, race/ethnicity had a significant effect both in bivariate and multivariate analyses. Non-MM patients had the lowest, and AA patients had the highest PB CD34+ cells. The results support the view that past therapies used in MM are likely more conducive of recovery of HSPC. Conclusions Our study shows that race/ethnicity and diagnostic group differences influenced CD34+ cell mobilization response across donor types. Interestingly, autologous MM donors with the aid of plerixafor displayed comparable CD34 yields to allogeneic donors. Even though both MM and non-MM donors received plerixafor, non-MM donors had significantly lower CD34 yields among AA and O donors but not in W donors. Larger studies would be required to validate the role of diagnostic groups and race/ethnicity interactions.

Published
2021

9. Noncirrhotic Hyperammonemia Causing Relapsing Altered Mental Status

Author

Binod Khatiwada, Chibuzo Clement Odigwe, Isaac Ikwu, Christopher M. Holbrook, Ifeoma Sylvia Ekeh, Bishwas Upadhyay, and Chukwuemeka Uzoka

Subjects
Pediatrics, medicine.medical_specialty, business.industry, Encephalopathy, MEDLINE, Hyperammonemia, General Medicine, medicine.disease, 03 medical and health sciences, Liver disease, Case Studies, 0302 clinical medicine, Altered Mental Status, 030220 oncology & carcinogenesis, Medicine, 030211 gastroenterology & hepatology, In patient, business
Abstract

Hyperammonemia is a recognized cause of encephalopathy. However, it is commonly seen in patients with liver disease. The clinical entity of noncirrhotic hyperammonemia is now being increasingly recognized. We report a man who presented to our hospital with relapsing altered mental status later diagnosed as noncirrhotic hyperammonemia.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results